Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Liminatus Pharma Inc. (LIMN) had Tangible Shareholders Equity of $-0.13M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.12M |
|
-- |
|
-- |
|
$1.10M |
|
$-1.10M |
|
$-0.02M |
|
$-1.12M |
|
$-1.12M |
|
$-1.12M |
|
$-1.12M |
|
$-1.12M |
|
$-1.12M |
|
$-1.10M |
|
$-1.10M |
|
36.00M |
|
36.00M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$2.78M |
|
$0.01M |
|
$0.01M |
|
$2.79M |
|
$2.89M |
|
-- |
|
$0.03M |
|
$2.92M |
|
$-0.13M |
|
|
Tangible Shareholders Equity |
$-0.13M |
$-0.13M |
|
44.88M |
|
| Cash Flow Statement Financials | |
$-2.02M |
|
-- |
|
$3.59M |
|
$0.34M |
|
$1.91M |
|
$1.57M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.96 |
|
-- |
|
-- |
|
-- |
|
-10.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
847.48% |
|
847.47% |
|
-40.27% |
|
847.47% |
|
$-0.00 |
|
$-0.06 |
|
$-0.06 |
|